Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus
N Katakami - Journal of atherosclerosis and thrombosis, 2018 - jstage.jst.go.jp
Diabetic macroangiopathy, atherosclerosis secondary to diabetes mellitus (DM), causes
cerebro-cardiovascular diseases, which are major causes of death in patients with DM and …
cerebro-cardiovascular diseases, which are major causes of death in patients with DM and …
Targeting RAGE signaling in inflammatory disease
BI Hudson, ME Lippman - Annual review of medicine, 2018 - annualreviews.org
The receptor for advanced glycation end-products (RAGE) is a multiligand pattern
recognition receptor implicated in diverse chronic inflammatory states. RAGE binds and …
recognition receptor implicated in diverse chronic inflammatory states. RAGE binds and …
Cellular signalling of the receptor for advanced glycation end products (RAGE)
J Xie, JD Méndez, V Méndez-Valenzuela… - Cellular signalling, 2013 - Elsevier
The receptor for advanced glycation end-product (RAGE) is the signal transduction receptor
which senses a variety of signalling molecules including advanced glycation end products …
which senses a variety of signalling molecules including advanced glycation end products …
RAGE regulation and signaling in inflammation and beyond
K Kierdorf, G Fritz - Journal of leukocyte biology, 2013 - academic.oup.com
ABSTRACT RAGE is a key molecule in the onset and sustainment of the inflammatory
response. New studies indicate that RAGE might represent a new link between the innate …
response. New studies indicate that RAGE might represent a new link between the innate …
Mechanisms, pathophysiology, and therapy of arterial stiffness
SJ Zieman, V Melenovsky, DA Kass - … , thrombosis, and vascular …, 2005 - Am Heart Assoc
Arterial stiffness is a growing epidemic associated with increased risk of cardiovascular
events, dementia, and death. Decreased compliance of the central vasculature alters arterial …
events, dementia, and death. Decreased compliance of the central vasculature alters arterial …
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
MT Lotze, KJ Tracey - Nature Reviews Immunology, 2005 - nature.com
High-mobility group box 1 protein (HMGB1), which previously was thought to function only
as a nuclear factor that enhances transcription, was recently discovered to be a crucial …
as a nuclear factor that enhances transcription, was recently discovered to be a crucial …
HMGB1 and RAGE in inflammation and cancer
GP Sims, DC Rowe, ST Rietdijk… - Annual review of …, 2009 - annualreviews.org
The immune system has evolved to respond not only to pathogens, but also to signals
released from dying cells. Cell death through necrosis induces inflammation, whereas …
released from dying cells. Cell death through necrosis induces inflammation, whereas …
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane, S Du Yan, RK Submamaryan, B LaRue… - Nature medicine, 2003 - nature.com
Amyloid-β peptide (Aβ) interacts with the vasculature to influence Aβ levels in the brain and
cerebral blood flow, providing a means of amplifying the Aβ-induced cellular stress …
cerebral blood flow, providing a means of amplifying the Aβ-induced cellular stress …
Understanding RAGE, the receptor for advanced glycation end products
A Bierhaus, PM Humpert, M Morcos, T Wendt… - Journal of molecular …, 2005 - Springer
Advanced glycation end products (AGEs), S100/calgranulins, HMGB1-proteins, amyloid-β
peptides, and the family of β-sheet fibrils have been shown to contribute to a number of …
peptides, and the family of β-sheet fibrils have been shown to contribute to a number of …
Advanced glycation end products and their effect on vascular complications in type 2 diabetes mellitus
J Lee, JS Yun, SH Ko - Nutrients, 2022 - mdpi.com
Diabetes is well established as a chronic disease with a high health burden due to mortality
or morbidity from the final outcomes of vascular complications. An increased duration of …
or morbidity from the final outcomes of vascular complications. An increased duration of …